f




Pharm Access Africa Limited Alumni


Florence Anam


Florence Anam holds a Bachelors of Business Administration (BBA) degree from Maseno University and is currently pursuing a Masters of Arts in Communication Studies from The University of Nairobi (UON).

Florence worked with Pharm Access Africa Limited Limited from mid-2009 to early 2012 on a HIV at Workplace Program at eight participating companies. Aureos and NORFUND funded this program. These companies were assisted to develop and implement HIV and health policies.
The top management of these companies jointly signed a commitment to address HIV stigma in the workplaces to enable uptake HIV prevention interventions and access HIV treatment and care.

“To date this remains one of my greatest achievements: not only for the program
deliverables realized, but on a personal basis having faced HIV related stigma in 2007 after being fired from my job because of my HIV positive status,” says Florence.










“PAAL was not only a workplace: it was a home from which I made friends, shared a lot, grew immensely both in skill and at a personal level. Because I had a boss who allowed me to be creative, I was able to find innovative ways to deliver on my tasks. I enjoyed my time there. At the end of the project I felt confident enough to take my lessons back into engaging with communities.” she adds.

In 2012, Florence Anam joined the National Empowerment Network of People Living with HIV (NEPHAK) as the Advocacy and Communications Manager where I managed the advocacy and communication portfolio as well as community health engagement activities as the liaison between People Living with HIV communities and Ministry Of Health. She later joined the International Community of Women Living with HIV (ICW) Global office based in Nairobi, Kenya from 2015 to 2018 were she worked as the Senior Manager Advocacy and Communication. After ICW Global Florence was the HIV/TB Advocacy coordinator for Africa region at Doctors without Borders (MSF) and is based in Johannesburg, South Africa. Currently Florence is the Co-Executive Director at GNP Plus.

Paul Maina

Paul joined Pharmacy Access Africa in June 2004 as the Chief Accountant. He was part of the innogural team of management of PAAL.

He held the position for 4 years heading the Finance team as well as overseeing human Resource matters. He left PAAL in May 2008.

Paul is a holder of BCom in Accounting and a Certified Public Accountant of Kenya and a member of ICPAK.

To me, PAAL was more than just workplace. It was family. The time spent there remains some of the most memorable in my career. The challenge of setting up systems in a new organization and the satisfaction that came with serving the community by ensuring accessibility to ARVs as part of APHIA partners ..was truly satisfying". He says.

Paul is currently working with KTDA as a senior manager heading the Factory Accounts department.

Jack Indusa Adaji

Jack Indusa Adaji joined in PAAL on July 2012 as a Commodity Security and Logistics Officer based in Nairobi.

He worked in the PAAL reproductive health project TUPANGE, a consortium funded by Bill and Melinda Gates Foundation (BMGF) and led by JHPIEGO, an international NGO affiliated with Johns Hopkins University with a consortium of partners including National Council of Population and Development (NCPD) under the Ministry of Planning and Devolution, Marie Stopes International (MSI) and PAAL whose responsibility was contraceptive commodity security.

“I was tasked to work with the private sector partner clinics and hospitals to capacity build them on Commodity Security and the logistics of the day to day handling of commodity, storage, distribution, correct ordering of commodities.”

“It was while working at PAAL that I gained more interest in working with the NGOs and the humanitarian world because of the imp[act the I saw we were impacting the community around us.”

The smartest way to secure your child’s future

Our Mission”

“To increase access to healthcare for peoples of Africa by ensuring accessibility to high quality drugs at the most affordable prices possible.”.